Trái phiếu
Sau đây là danh sách trái phiếu doanh nghiệp GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs. Các nhà đầu tư thường lựa chọn trái phiếu của công ty vì tính ổn định cao hơn trong thời điểm thị trường biến động. Nghiên cứu giá cả, lợi suất và các số liệu thống kê khác và tìm khoản đầu tư đáng tin cậy.
Mã | Lợi suất đáo hạn % | Khối lượng | Giá % | Phiếu giảm giá % | Ngày đáo hạn | Giá trị dư nợ | Giá trị khuôn mặt | Giá trị mệnh giá tối thiểu | Bên phát hành |
|---|---|---|---|---|---|---|---|---|---|
| XXS86659697GlaxoSmithKline Capital Plc 4.25% 18-DEC-2045 | 5.72% | 0 | 82.57% | 4.250% | 2045-12-18 | 370.79 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| XXS29462437GlaxoSmithKline Capital Plc 5.25% 10-APR-2042 | 5.61% | 0 | 96.09% | 5.250% | 2042-04-10 | 477.82 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| XXS35082093GlaxoSmithKline Capital Plc 6.375% 09-MAR-2039 | 5.44% | 0 | 108.66% | 6.375% | 2039-03-09 | 631.3 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGX4CGlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5.18% | 0 | 88.78% | 4.200% | 2043-03-18 | 500 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035 | 4.99% | 0 | 74.89% | 1.625% | 2035-05-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AE7GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 4.92% | 0 | 113.52% | 6.375% | 2038-05-15 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377372AQ0GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | 4.61% | 0 | 101.96% | 4.875% | 2035-04-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS14051686GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033 | 4.55% | 0 | 104.70% | 5.250% | 2033-12-19 | 574.17 M GBP | 1,000.00 GBP | 1,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AB3GlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034 | 4.46% | 0 | 106.35% | 5.375% | 2034-04-15 | 500 M USD | 1,000.00 USD | 1,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS86658852GlaxoSmithKline Capital Plc 3.375% 20-DEC-2027 | 4.11% | 0 | 98.53% | 3.375% | 2027-12-20 | 307.77 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AP2GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | 4.06% | 0 | 101.78% | 4.500% | 2030-04-15 | 850 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028 | 3.98% | 0 | 92.49% | 1.250% | 2028-10-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029 | 3.95% | 0 | 98.08% | 3.375% | 2029-06-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028 | 3.88% | 0 | 100.00% | 3.875% | 2028-05-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AM7GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | 3.79% | 0 | 100.71% | 4.315% | 2027-03-12 | 400 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| XXS293369275GSK Capital BV 3.25% 19-NOV-2036 | 3.48% | 0 | 97.88% | 3.250% | 2036-11-19 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS255381776GSK Capital BV 3.125% 28-NOV-2032 | 3.09% | 0 | 100.18% | 3.125% | 2032-11-28 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS293369143GSK Capital BV 2.875% 19-NOV-2031 | 2.98% | 0 | 99.42% | 2.875% | 2031-11-19 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030 | 2.75% | 0 | 95.76% | 1.750% | 2030-05-21 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029 | 2.61% | 0 | 95.49% | 1.375% | 2029-09-12 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK Capital BV 3.0% 28-NOV-2027 | 2.39% | 0 | 101.23% | 3.000% | 2027-11-28 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026 | 2.24% | 0 | 99.44% | 1.250% | 2026-05-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026 | 2.19% | 0 | 98.97% | 1.000% | 2026-09-12 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | — | 1.48 M | 100.35% | 4.727% | 2027-03-12 | 600 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-2028 | — | — | — | 0.883% | 2028-09-21 | 42.5 B JPY | 100,000,000.00 JPY | 100,000,000.00 JPY | GlaxoSmithKline Capital Plc |